Christopher Wilke (@cwilkemdphd) 's Twitter Profile
Christopher Wilke

@cwilkemdphd

Radiation oncologist at @UPMCHillmanCC specializing in #hnscm. Tweets are my own.

ID: 1303405041995468800

calendar_today08-09-2020 18:49:32

36 Tweet

164 Takipçi

129 Takip Edilen

@UMNRadOnc (@umnradonc) 's Twitter Profile Photo

Congratulations to Dr. Stephanie Terezakis on being named Department Head of Radiation Oncology! Thank you, Dr. Kathryn Dusenbery for your excellent and strong leadership of the department over the past 21 years!! Stephanie Terezakis Katie UMN Medical School

Christopher Wilke (@cwilkemdphd) 's Twitter Profile Photo

Big shout out to our resident, Dr. Easwaran, who, in addition to curing cancer for her day job, volunteered in our ICU over the holidays. @UMNRadOnc

Christopher Wilke (@cwilkemdphd) 's Twitter Profile Photo

Heading back to MN after a great NRG Oncology meeting. Great to catch up with a lot of old colleagues in person and discuss the latest in clinical trials and translational research. Looking forward to FL in 6 months!

Christopher Wilke (@cwilkemdphd) 's Twitter Profile Photo

Fantastic job by our LSSURP student Jessica O. who presented work on custom 3D printer brachy applicators that she helped developed. Great to have you in the clinic and lab this summer! ⁦@DavidMedPhys⁩ ⁦⁦University of Minnesota MD-PhD Program

Fantastic job by our LSSURP student Jessica O. who presented work on custom 3D printer brachy applicators that she helped developed. Great to have you in the clinic and lab this summer! ⁦@DavidMedPhys⁩ ⁦⁦<a href="/UMNMSTP/">University of Minnesota MD-PhD Program</a>⁩
Pierre Blanchard, MD (@pblanchardmd) 's Twitter Profile Photo

The #GORTEC PembroRad trial is out Annals of Oncology Concomitant pembrolizumab and #radiotherapy for locally advanced head neck cancer #hncsm TL/DR: pembro-RT less toxic but not more efficacious Full text: annalsofoncology.org/article/S0923-…

The #GORTEC PembroRad trial is out <a href="/Annals_Oncology/">Annals of Oncology</a> 

Concomitant pembrolizumab and #radiotherapy for locally advanced head neck cancer #hncsm 

TL/DR: pembro-RT less toxic but not more efficacious

Full text: annalsofoncology.org/article/S0923-…
Heath Skinner, MD PhD (@hskinnermdphd) 's Twitter Profile Photo

I am so very excited to welcome Dr. Yvonne Mowery, who will be joining us UPMC Hillman Cancer Center University of Pittsburgh later this year. Dr. Mowery is an accomplished #physicianscientist and #radonc whose work focuses on developing novel radiosensitizers and animal models of #HNSCC. Currently, she

I am so very excited to welcome Dr. <a href="/YvonneMowery/">Yvonne Mowery</a>, who will be joining us <a href="/UPMCHillmanCC/">UPMC Hillman Cancer Center</a> <a href="/PittTweet/">University of Pittsburgh</a> later this year. Dr. Mowery is an accomplished #physicianscientist and #radonc whose work focuses on developing novel radiosensitizers and animal models of #HNSCC. Currently, she
Lady Glaucomflecken (she/her) (@lglaucomflecken) 's Twitter Profile Photo

In my 10+ years of co-survivorship, doing life with Dr. Glaucomflecken through 2 separate cancers, 1 SCA and fighting off his death with 10 mins of #CPR, only ONE (1) of the medical professionals we interacted with has ever asked how I was doing. Meet Roger. authors.elsevier.com/a/1giY02p-l5Vhe

Susannah Ellsworth (@free_radical28) 's Twitter Profile Photo

PROSPECT study: nejm.org/doi/full/10.10…. A number of insightful threads out there already re: trial results and future directions especially in the context of TNT and increasing demand for organ sparing approaches in locally advanced #rectalcancer. Krishan Jethwa Prajnan Das, MD, MS, MPH

Heath Skinner, MD PhD (@hskinnermdphd) 's Twitter Profile Photo

We are so excited to welcome Yvonne Mowery and look forward to her expanding on her already incredible work, including an early phase trial of #SBRT + #DDRi + #Immunotherapy in #hnscc that is currently recruiting! University of Pittsburgh

PDBrown (@pdbrownonc) 's Twitter Profile Photo

Reminder for IDHmutant glioma homozygous deletion CDKN2A/B makes it grade 4 (WHO CNS-5) journals.lww.com/co-neurology/A…

Reminder for IDHmutant glioma homozygous deletion CDKN2A/B makes it grade 4 (WHO CNS-5) journals.lww.com/co-neurology/A…
Heath Skinner, MD PhD (@hskinnermdphd) 's Twitter Profile Photo

I am thrilled to announce that we have treated our first SCINTIX patient on the RefleXion Medical X1 in #radonc UPMC Hillman Cancer Center. This represents one of the first patients in the world to be treated using this tracer guided delivery of #radiation to treat cancer and the culmination of

I am thrilled to announce that we have treated our first SCINTIX patient on the <a href="/reflexionmed/">RefleXion Medical</a> X1 in #radonc <a href="/UPMCHillmanCC/">UPMC Hillman Cancer Center</a>. 
This represents one of the first patients in the world to be treated using this tracer guided delivery of #radiation to treat cancer and the culmination of